Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
- Sites to continue enrollment up to 250 patients in sexual function trial - ENGLEWOOD, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that …